Immunotherapy News and Research

Latest Immunotherapy News and Research

Monitoring ctDNA can personalize the use of consolidation immunotherapy in patients with LS-SCLC

Monitoring ctDNA can personalize the use of consolidation immunotherapy in patients with LS-SCLC

New strategy for difficult-to-treat mesothelioma: Immunotherapy and ctDNA insights

New strategy for difficult-to-treat mesothelioma: Immunotherapy and ctDNA insights

Tarlatamab and anti-PD-L1 therapy combination demonstrates manageable safety profile in first-line ES-SCLC

Tarlatamab and anti-PD-L1 therapy combination demonstrates manageable safety profile in first-line ES-SCLC

HypoRT with concurrent chemotherapy reduces treatment time and toxicity for patients with LS-SCLC

HypoRT with concurrent chemotherapy reduces treatment time and toxicity for patients with LS-SCLC

Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests

Adjuvant chemo-immunotherapy may benefit patients with resected stage IB–IIIA NSCLC, trial suggests

New drug candidate STF 1623 activates innate immunity in solid tumors

New drug candidate STF 1623 activates innate immunity in solid tumors

WHO expands essential medicines lists with new cancer and diabetes treatments

WHO expands essential medicines lists with new cancer and diabetes treatments

Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer

Targeting metabolic reprogramming to overcome immune suppression in head and neck cancer

Oncolytic viruses integrated with immunotherapy for next-generation cancer treatment

Oncolytic viruses integrated with immunotherapy for next-generation cancer treatment

Targeting ADAR1 offers new hope against glioblastoma

Targeting ADAR1 offers new hope against glioblastoma

Plant-derived carotenoid found to boost immune response against cancer

Plant-derived carotenoid found to boost immune response against cancer

Cancer-related nerve injury triggers inflammation and immunotherapy resistance

Cancer-related nerve injury triggers inflammation and immunotherapy resistance

Scientists discover molecular brake that limits T cell attack on tumors

Scientists discover molecular brake that limits T cell attack on tumors

New off-the-shelf immunotherapy for metastatic kidney cancer could help improve outcomes

New off-the-shelf immunotherapy for metastatic kidney cancer could help improve outcomes

Researchers identify genetic toolkit to reprogram cells into immune sentinels

Researchers identify genetic toolkit to reprogram cells into immune sentinels

Tumor microbiota identified as predictors of prognosis in gastrointestinal cancers

Tumor microbiota identified as predictors of prognosis in gastrointestinal cancers

New NIH-funded project aims to turn rare HIV cures into broadly applicable immunotherapy

New NIH-funded project aims to turn rare HIV cures into broadly applicable immunotherapy

New advances offer hope in the fight against KRAS-driven pancreatic cancer

New advances offer hope in the fight against KRAS-driven pancreatic cancer

New method uncovers how extracellular vesicles impact immune response in cancer

New method uncovers how extracellular vesicles impact immune response in cancer

Diabetes-altered blood particles suppress immune defense in breast cancer

Diabetes-altered blood particles suppress immune defense in breast cancer

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.